CMG Pitavastatin Tablet 2mg (Pitavastatin Calcium Hydrate)

Adult dose

For adults, the usual initial dose is 1 to 2 milligrams of pitavastatin calcium, taken once daily. If the LDL-cholesterol-reducing effect is insufficient, the dose may be increased to a maximum of 4 milligrams daily. The dose should be adjusted appropriately at intervals of 4 weeks or more based on LDL-cholesterol levels, treatment goals, and patient response.

This medication should not be administered to certain patients. For example, patients with allergies to this medication or with active liver disease, severe liver impairment, or bile duct obstruction, patients taking cyclosporine, those with myopathy, pregnant or potentially pregnant women, nursing mothers, and pediatric patients should not use this medication. Additionally, patients with impaired kidney function or a history of liver disease, individuals who excessively consume alcohol, and those on fibric acid derivatives or niacin, patients with hypothyroidism, elderly individuals, etc., should use this medication with caution. While taking this medication, various side effects such as muscle pain, fatigue, liver function abnormalities, skin rashes, and blood abnormalities may occur, so if any symptoms appear, medical consultation should be sought immediately. Notably, muscle-related symptoms may progress to a serious condition called rhabdomyolysis, necessitating vigilance. Since this medication is primarily metabolized in the liver, regular liver function tests should be conducted, and administration should be stopped if abnormalities are found. Also, patients with a risk of diabetes should periodically check their blood glucose levels. When taking this medication with other drugs, interactions may occur, especially if co-administered with cyclosporine, fibric acid derivatives, niacin, erythromycin, etc. If symptoms appear during co-administration with these drugs, administration should be halted immediately due to potential muscle damage or worsening kidney function. Elderly patients should exercise greater caution as the risk of adverse reactions is higher. Pregnant or nursing women should not take this medication as it may pose risks to the fetus or newborn. If pregnancy is confirmed, administration should be stopped immediately. The safety and efficacy of this medication in pediatric patients have not been established, hence it should not be used in children. Finally, this medication should be kept out of the reach of children and stored in its original container to prevent misuse and preserve its quality.

Serious side effects

• Hives
• severe swelling (edema)
• chest tightness
• difficulty breathing
• rhabdomyolysis
• acute renal failure
• severe kidney impairment
• liver function impairment
• jaundice
• thrombocytopenia

Mild side effects

Abdominal pain, rash, fatigue, paresthesia, itching, stiffness, drowsiness, insomnia, headache, dry mouth, dyspepsia, abdominal bloating, constipation, stomatitis, vomiting, loss of appetite, glossitis, nausea, discomfort in the stomach, diarrhea, granulocytopenia, leukopenia, eosinophilia, leukocytosis, elevated globulin, positive Coombs test, anemia, increased urination, elevated BUN, increased serum creatinine, decreased aldosterone, elevated aldosterone, adrenal cortex-stimulating hormone elevation

This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is important to maintain room temperature, between 1 degree and 30 degrees Celsius, while storing the medication. Doing so ensures the medication's effectiveness and safety for use.

Appearance

Very pale yellowish-red round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle